Clinical and Genetic Predictors of Non‐Alcoholic Steatotic Liver Disease and Fibrosis in Lean Individuals
Diabetes serves as a primary predictor of non-alcoholic SLD in lean individuals. These results support the recommendation to screen for SLD in patients with diabetes, regardless of BMI. The GCKR risk allele is associated with MASLD in lean individuals, and the risk factors for cryptogenic SLD remain unclear.
Authors
- Kirk J. Wangensteen (ORCID: https://orcid.org/0000-0001-6042-6490)
- Karina Sato‐Espinoza (ORCID: https://orcid.org/0000-0002-1725-5865)
- Konstantinos N. Lazaridis (ORCID: https://orcid.org/0000-0002-0437-681X)
- Robert A. Vierkant (ORCID: https://orcid.org/0000-0001-6242-5221)
- Alina M. Allen (ORCID: https://orcid.org/0000-0002-8393-8410)
- Carolin Victoria Schneider (ORCID: https://orcid.org/0000-0002-6728-9246)
- Filippo Pinto e Vairo (ORCID: https://orcid.org/0000-0001-6030-1903)
- Carola Dlugosch
- Daniel R. O’Brien (ORCID: https://orcid.org/0000-0003-0740-7447)
- Jun Ma (ORCID: https://orcid.org/0000-0003-4354-2523)
- Shulan Tian (ORCID: https://orcid.org/0000-0002-3348-7439)
- Perapa Chotiprasidhi
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Liver International
- Published
- 2025-09-13
- DOI
- https://doi.org/10.1111/liv.70300
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35